Award recognises ICON’s business leadership, growth, innovation and employee development
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded Company of the Year at the annual Business & Finance Irish Business Awards, which took place in Dublin on December 15th.
The Business & Finance Irish Business Awards have been recognising excellence in Irish business for over 40 years and is the longest running and most coveted business awards programme in Ireland. The company of the year award recognises the company that best demonstrates outstanding business leadership, sustainable growth, innovative strategy, strong financial returns and employee development.
Commenting on the award, ICON’s Chief Executive Officer, Ciaran Murray, said: “We are honoured to be chosen as Ireland’s company of the year for 2016. Since our foundation in Dublin in 1990, we have grown to become a global leader in clinical research, helping our clients to bring medicines to market that are improving peoples’ lives right across the world. We have achieved this through a focus on operational excellence, quality, innovation and an unyielding commitment to patients and to our clients and I’m delighted that the efforts of our employees are being recognised.”
View full details of the Business & Finance Irish Business Awards
About ICON plc
ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 88 locations in 37 countries and has approximately 12,600 employees.
ICON Media Contact
Director Corporate Communications, ICON plc
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are available on the SEC's website at http://www.sec.gov.